Specialklinikken Rebild ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  2.0% 2.0% 1.2% 1.9% 25.3%  
Credit score (0-100)  70 70 85 72 3  
Credit rating  A A A A B  
Credit limit (kDKK)  0.3 0.5 126.1 0.4 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12

Net sales  0 0 0 0 0  
Gross profit  1,804 2,660 2,003 1,374 -29.7  
EBITDA  1,489 2,105 1,537 932 -60.4  
EBIT  1,389 1,789 1,158 167 -903  
Pre-tax profit (PTP)  1,388.7 1,788.4 1,111.8 126.6 -920.2  
Net earnings  1,082.2 1,384.8 859.1 95.5 -915.9  
Pre-tax profit without non-rec. items  1,389 1,788 1,112 127 -920  

 
See the entire income statement

Balance sheet (kDKK) 
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12

Tangible assets total  1,836 1,651 1,601 902 35.5  
Shareholders equity total  1,132 2,017 1,576 872 -244  
Interest-bearing liabilities  1,565 1,834 2,724 268 199  
Balance sheet total (assets)  3,110 4,732 5,159 1,626 76.3  

Net Debt  334 -1,001 -749 -404 160  
 
See the entire balance sheet

Volume 
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,804 2,660 2,003 1,374 -29.7  
Gross profit growth  0.0% 47.4% -24.7% -31.4% 0.0%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  3,110 4,732 5,159 1,626 76  
Balance sheet change%  0.0% 52.1% 9.0% -68.5% -95.3%  
Added value  1,489.1 2,104.9 1,537.1 546.1 -60.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  1,736 -502 -429 -1,463 -1,709  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 4.0 -1.0  

Profitability 
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  77.0% 67.2% 57.8% 12.2% 3,037.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  44.7% 45.6% 23.7% 4.9% -92.8%  
ROI %  50.0% 53.1% 28.0% 6.0% -134.4%  
ROE %  95.6% 87.9% 47.8% 7.8% -193.2%  

Solidity 
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
Equity ratio %  36.4% 42.6% 30.6% 53.6% -76.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  22.4% -47.6% -48.7% -43.4% -264.4%  
Gearing %  138.2% 90.9% 172.8% 30.7% -81.6%  
Net interest  0 0 0 0 0  
Financing costs %  0.1% 0.0% 2.6% 2.7% 7.5%  

Liquidity 
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
Quick Ratio  0.7 1.2 1.0 0.9 0.1  
Current Ratio  0.7 1.2 1.0 0.9 0.1  
Cash and cash equivalent  1,231.4 2,835.9 3,473.0 671.9 39.7  

Capital use efficiency 
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -660.1 435.8 37.5 -67.3 -279.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
Net sales / employee  0 0 0 0 0  
Added value / employee  1,489 2,105 1,537 546 -60  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  1,489 2,105 1,537 932 -60  
EBIT / employee  1,389 1,789 1,158 167 -903  
Net earnings / employee  1,082 1,385 859 96 -916